Gencurix Company Description

Gencurix Inc. provides diagnostic solutions in South Korea.

Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection.

The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform.

The company was founded in 2011 and is headquartered in Seoul, South Korea.

Gencurix Inc.

Country	South Korea
Founded	2011
Industry	Medical - Specialties
Sector	Healthcare
CEO	Sung-Rai Cho

Contact Details

Address: Hanhwa Bizmetro Seoul, 152-733 South Korea
Phone	82 2 2621 7038
Website	gencurix.com

Stock Details

Ticker Symbol	229000
Exchange	KOSDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	KRW
ISIN Number	KR7229000005
SIC Code	2835

Key Executives

Name	Position
Sung-Rai Cho	Chief Executive Officer